Literature DB >> 984779

Comparison of activity of sisomicin and gentamicin in mouse protection tests with gram-negative bacilli.

B R Meyers, S Z Hirschman.   

Abstract

The efficacy of sisomicin and gentamicin was compared in mouse protection studies against strains of Escherichia coli, Klebsiella sp., Enterobacter aerogenes, Serratia marcescens, Proteus mirabilis, and Pseudomonas aeruginosa. There was no significant difference in mortality of the mice in any of the protocol groups when five different dosages of sisomicin and gentamicin given by three separate schedules were compared for each bacterial inoculum in each antibiotic protocol. The mean protective dose values of sisomicin were at least one-half those of gentamicin for each protocol against Pseudomonas aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984779      PMCID: PMC429753          DOI: 10.1128/AAC.10.2.384

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Clinical pharmacology of sisomicin.

Authors:  V Rodriguez; G P Bodey; M Valdivieso; R Feld
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  Activity of gentamicin, tobramycin, polymyxin B, and colistimethate in mouse protection tests with Pseudomonas aeruginosa.

Authors:  S D Davis
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

3.  Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic.

Authors:  M J Weinstein; J A Marquez; R T Testa; G H Wagman; E M Oden; J A Waitz
Journal:  J Antibiot (Tokyo)       Date:  1970-11       Impact factor: 2.649

4.  [Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin].

Authors:  H Lode; B Kemmerich; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

5.  Comparison of the antibacterial activities of sisomicin and gentamicin against gram-negative bacteria.

Authors:  B R Meyers; B Leng; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

6.  Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin.

Authors:  J A Waitz; E L Moss; C G Drube; M J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

7.  Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.

Authors:  C C Crowe; E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

8.  Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus.

Authors:  L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

9.  In vitro bactericidal effectiveness of four aminoglycoside antibiotics.

Authors:  P J Hyams; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

  9 in total
  2 in total

Review 1.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

2.  Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in mice.

Authors:  R V Goering; C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.